Cargando…

miR-155 as a Biomarker in B-Cell Malignancies

MicroRNAs have the potential to be useful biomarkers in the development of individualized treatment since they are easy to detect, are relatively stable during sample handling, and are important determinants of cellular processes controlling pathogenesis, progression, and response to treatment of se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Due, Hanne, Svendsen, Pernille, Bødker, Julie Støve, Schmitz, Alexander, Bøgsted, Martin, Johnsen, Hans Erik, El-Galaly, Tarec Christoffer, Roug, Anne Stidsholt, Dybkær, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884835/ https://www.ncbi.nlm.nih.gov/pubmed/27294145 http://dx.doi.org/10.1155/2016/9513037

Ejemplares similares

Normal myeloid progenitor cell subset-associated gene signatures for acute myeloid leukaemia subtyping with prognostic impact
por: Schönherz, Anna A., et al.
Publicado: (2020)

Implementing the FAIR Data Principles in precision oncology: review of supporting initiatives
por: Vesteghem, Charles, et al.
Publicado: (2019)

Molecular classification of tissue from a transformed non-Hogkin’s lymphoma case with unexpected long-time remission
por: Bødker, Julie Støve, et al.
Publicado: (2017)

hemaClass.org: Online One-By-One Microarray Normalization and Classification of Hematological Cancers for Precision Medicine
por: Falgreen, Steffen, et al.
Publicado: (2016)

MicroRNAs in B-cells: from normal differentiation to treatment of malignancies
por: Marques, Sara Correia, et al.
Publicado: (2014)

Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow – A proof of concept study
por: Nørgaard, Caroline Holm, et al.
Publicado: (2018)

The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines
por: Reinholdt, Linn, et al.
Publicado: (2016)

Exposure time independent summary statistics for assessment of drug dependent cell line growth inhibition
por: Falgreen, Steffen, et al.
Publicado: (2014)

Long Noncoding RNA Expression during Human B-Cell Development
por: Petri, Andreas, et al.
Publicado: (2015)

Reproducible probe-level analysis of the Affymetrix Exon 1.0 ST array with R/Bioconductor
por: Rodrigo-Domingo, Maria, et al.
Publicado: (2014)

Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models
por: Falgreen, Steffen, et al.
Publicado: (2015)

A model system for assessing and comparing the ability of exon microarray and tag sequencing to detect genes specific for malignant B-cells
por: Kloster, Maria Bro, et al.
Publicado: (2012)

The mutational profile of immune surveillance genes in diagnostic and refractory/relapsed DLBCLs
por: Nesic, Marijana, et al.
Publicado: (2021)

High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients
por: Laursen, Maria Bach, et al.
Publicado: (2019)

Development of a Precision Medicine Workflow in Hematological Cancers, Aalborg University Hospital, Denmark
por: Bødker, Julie S., et al.
Publicado: (2020)

Molecular Characteristics of High-Dose Melphalan Associated Oral Mucositis in Patients with Multiple Myeloma: A Gene Expression Study on Human Mucosa
por: Marcussen, Mette, et al.
Publicado: (2017)

Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma
por: Marcussen, Mette, et al.
Publicado: (2018)

Proof of the Concept to Use a Malignant B Cell Line Drug Screen Strategy for Identification and Weight of Melphalan Resistance Genes in Multiple Myeloma
por: Bøgsted, Martin, et al.
Publicado: (2013)

Unaccounted uncertainty from qPCR efficiency estimates entails uncontrolled false positive rates
por: Bilgrau, Anders E., et al.
Publicado: (2016)

MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index
por: Due, Hanne, et al.
Publicado: (2020)

Validation and implementation of a method for microarray gene expression profiling of minor B-cell subpopulations in man
por: Bergkvist, Kim Steve, et al.
Publicado: (2014)

A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myeloma
por: Issa, Issa Ismail, et al.
Publicado: (2021)

Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission – results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial
por: Schmitz, Alexander, et al.
Publicado: (2022)

Effects of chemotherapy dose reductions in overweight patients with acute myeloid leukaemia: A Danish nationwide cohort study
por: Kristensen, Daniel Tuyet, et al.
Publicado: (2022)

Expression of NOTCH3 exon 16 differentiates Diffuse Large B-cell Lymphoma into molecular subtypes and is associated with prognosis
por: Jespersen, Ditte Starberg, et al.
Publicado: (2019)

Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study
por: Tuyet Kristensen, Daniel, et al.
Publicado: (2023)

Late relapses in Hodgkin lymphoma – should we search for the needle in the haystack?
por: El‐Galaly, Tarec Christoffer, et al.
Publicado: (2022)

A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment
por: Jensen, Paw, et al.
Publicado: (2022)

Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients
por: Jensen, Oda, et al.
Publicado: (2022)

Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
por: Madsen, Marie Lindhard, et al.
Publicado: (2019)

A novel unbalanced de novo translocation der(5)t(4;5)(q26;q21.1) in adult T-cell precursor lymphoblastic leukemia
por: Kjeldsen, Eigil, et al.
Publicado: (2012)

Limited value of routine follow-up visits in chronic lymphocytic leukemia managed initially by watch and wait: A North Denmark population-based study
por: Nørgaard, Caroline Holm, et al.
Publicado: (2018)

Estimating the loss of lifetime function using flexible parametric relative survival models
por: Jakobsen, Lasse H., et al.
Publicado: (2019)

Optimization of Preanalytical Variables for cfDNA Processing and Detection of ctDNA in Archival Plasma Samples
por: Nesic, Marijana, et al.
Publicado: (2021)

Hsp90 inhibition sensitizes DLBCL cells to cisplatin
por: Schmidt, Linnéa, et al.
Publicado: (2022)

Shared care follow-up of patients with B-cell neoplasms based on nurse-led telephone consultations and PRO-data: a feasibility study from the North Denmark Region
por: Sommer, Mia, et al.
Publicado: (2020)

PB2706: NO DIFFERENCE IN SURVIVAL OUTCOMES BETWEEN IMMIGRANTS AND DANISH-BORN CITIZENS WITH A HEMATOLOGICAL MALIGNANCY: A NATIONWIDE, POPULATION-BASED REGISTER STUDY
por: Baech, Joachim, et al.
Publicado: (2023)

Simplicity at the cost of predictive accuracy in diffuse large B‐cell lymphoma: a critical assessment of the R‐IPI, IPI, and NCCN‐IPI
por: Biccler, Jorne, et al.
Publicado: (2017)

On estimating the time to statistical cure
por: Jakobsen, Lasse H., et al.
Publicado: (2020)

Patient-reported outcomes in patients with hematological relapse or progressive disease: a longitudinal observational study
por: Sommer, Mia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dv92sbot00pes1p3dlfo3lptji